Literature DB >> 17189685

Synthesis and HIV-1 integrase inhibitory activity of spiroundecane(ene) derivatives.

Elvira E Shults1, Elena A Semenova, Allison A Johnson, Svetlana P Bondarenko, Irina Y Bagryanskaya, Yuri V Gatilov, Genrikh A Tolstikov, Yves Pommier.   

Abstract

Fifteen 2,4-dioxaspiro[5.5]undecane ketone and 2,4-dioxa-spiro[5.5]undec-8-ene (spiroundecane(ene)) derivatives were synthesized using the Diels-Alder reaction. Inhibition of human immunodeficiency virus integrase (IN) was examined. Eight spiroundecane(ene) derivatives inhibited both 3'-processing and strand transfer reactions catalyzed by IN. SAR studies showed that the undecane core with at least one furan moiety is preferred for IN inhibition. Moreover, crosslinking experiments showed that spiroundecane derivatives did not affect IN-DNA binding at concentrations that block IN catalytic activity, indicating spiroundecane derivatives inhibit preformed IN-DNA complex. The moderate toxicity of spiroundecane(ene) derivatives encourages the further design of therapeutically relevant analogues based on this novel chemotype of IN inhibitors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17189685      PMCID: PMC1899478          DOI: 10.1016/j.bmcl.2006.11.094

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  17 in total

1.  Multiple integrase functions are required to form the native structure of the human immunodeficiency virus type I intasome.

Authors:  H Chen; S Q Wei; A Engelman
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

2.  Organocatalytic asymmetric domino knoevenagel/diels-alder reactions: a bioorganic approach to the diastereospecific and enantioselective construction of highly substituted spiro[5,5]undecane-1,5,9-triones.

Authors:  D B Ramachary; Naidu S Chowdari; Carlos F Barbas
Journal:  Angew Chem Int Ed Engl       Date:  2003-09-15       Impact factor: 15.336

3.  Mechanisms and inhibition of HIV integration.

Authors:  Christophe Marchand; Allison A Johnson; Elena Semenova; Yves Pommier
Journal:  Drug Discov Today Dis Mech       Date:  2006-07-01

Review 4.  HIV-1 integration: an interplay between HIV-1 integrase, cellular and viral proteins.

Authors:  Bénédicte Van Maele; Zeger Debyser
Journal:  AIDS Rev       Date:  2005 Jan-Mar       Impact factor: 2.500

Review 5.  HIV-1 integrase inhibitors: 2003-2004 update.

Authors:  Raveendra Dayam; Jinxia Deng; Nouri Neamati
Journal:  Med Res Rev       Date:  2006-05       Impact factor: 12.944

6.  Preferential inhibition of the magnesium-dependent strand transfer reaction of HIV-1 integrase by alpha-hydroxytropolones.

Authors:  Elena A Semenova; Allison A Johnson; Christophe Marchand; David A Davis; Robert Yarchoan; Yves Pommier
Journal:  Mol Pharmacol       Date:  2006-01-17       Impact factor: 4.436

Review 7.  Integrase inhibitors to treat HIV/AIDS.

Authors:  Yves Pommier; Allison A Johnson; Christophe Marchand
Journal:  Nat Rev Drug Discov       Date:  2005-03       Impact factor: 84.694

8.  Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition.

Authors:  M D Miller; C M Farnet; F D Bushman
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

9.  Integration requires a specific interaction of the donor DNA terminal 5'-cytosine with glutamine 148 of the HIV-1 integrase flexible loop.

Authors:  Allison A Johnson; Webster Santos; Godwin C G Pais; Christophe Marchand; Ronak Amin; Terrence R Burke; Gregory Verdine; Yves Pommier
Journal:  J Biol Chem       Date:  2005-10-27       Impact factor: 5.157

10.  Studies toward a marine toxin immunogen: enantioselective synthesis of the spirocyclic imine of (-)-gymnodimine.

Authors:  Ke Kong; Ziad Moussa; Daniel Romo
Journal:  Org Lett       Date:  2005-11-10       Impact factor: 6.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.